Published in J Clin Oncol on June 10, 2008
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A (2010) 4.95
Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev (2010) 3.77
Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle (2009) 3.68
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell (2013) 3.08
Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell (2010) 2.43
Cancer stem cells in the development of liver cancer. J Clin Invest (2013) 2.06
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol (2010) 1.91
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer. Cell (2015) 1.89
Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. Cancer Res (2010) 1.82
Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol (2009) 1.55
Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma. PLoS One (2016) 1.48
Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol (2011) 1.43
DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem (2011) 1.40
Functional analysis of microRNAs in human hepatocellular cancer stem cells. J Cell Mol Med (2012) 1.35
Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells (2009) 1.33
Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology (2009) 1.31
On the stem cell origin of cancer. Am J Pathol (2010) 1.21
Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs (2010) 1.20
The role of stem cells in liver repair and fibrosis. Int J Biochem Cell Biol (2009) 1.09
Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells. PLoS One (2013) 1.05
MicroRNAs involved in neoplastic transformation of liver cancer stem cells. J Exp Clin Cancer Res (2010) 1.04
Liver development, regeneration, and carcinogenesis. J Biomed Biotechnol (2010) 1.02
Pathophysiology of ocular surface squamous neoplasia. Exp Eye Res (2014) 1.02
Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World J Gastroenterol (2014) 1.00
Experimental models of hepatocellular carcinoma: developments and evolution. J Cancer Res Clin Oncol (2009) 0.98
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells. Cancer Cell (2016) 0.93
Cancer stem cells: repair gone awry? J Oncol (2010) 0.92
β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res (2014) 0.91
Hepatic progenitor cells express SerpinB3. BMC Cell Biol (2014) 0.89
Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells. Int J Exp Pathol (2010) 0.88
Molecular mechanisms underlying hepatocellular carcinoma. Viruses (2009) 0.87
Overexpression of Dickkopf 3 in hepatoblastomas and hepatocellular carcinomas. Virchows Arch (2009) 0.86
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma. J Gastroenterol (2010) 0.86
Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells. PLoS One (2013) 0.84
Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells. Arch Pathol Lab Med (2010) 0.84
Prostate Cancer Stem Cells: Research Advances. Int J Mol Sci (2015) 0.84
Upregulated microRNA-92b regulates the differentiation and proliferation of EpCAM-positive fetal liver cells by targeting C/EBPß. PLoS One (2013) 0.82
Diabetes mellitus and metformin in hepatocellular carcinoma. World J Gastroenterol (2016) 0.82
Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma. PLoS One (2010) 0.82
Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation. Sci Rep (2016) 0.81
p53 on the crossroad between regeneration and cancer. Cell Death Differ (2016) 0.80
Role of liver stem cells in hepatocarcinogenesis. World J Stem Cells (2014) 0.79
Retracted Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells. J Biol Chem (2014) 0.79
Isolation of CD133+ liver stem cells for clonal expansion. J Vis Exp (2011) 0.79
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B. Cytotechnology (2014) 0.78
Human cancer classification: a systems biology- based model integrating morphology, cancer stem cells, proteomics, and genomics. J Cancer (2011) 0.78
The controversial clinicobiological role of breast cancer stem cells. J Oncol (2009) 0.78
Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet. Hepatology (2010) 0.78
Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice. J Biol Chem (2016) 0.78
Hepatic progenitor cells in canine and feline medicine: potential for regenerative strategies. BMC Vet Res (2014) 0.78
A rare case of adult hepatoblastoma with neuroendocrine differentiation misdiagnosed as neuroendocrine tumor. Int J Clin Exp Pathol (2013) 0.78
Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes. Hepat Med (2010) 0.77
Moving targets in hepatocellular carcinoma: hepatic progenitor cells as novel targets for tyrosine kinase inhibitors. Gastroenterology (2008) 0.77
A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules. Theor Biol Med Model (2014) 0.76
Knockdown of caveolin-1 by siRNA inhibits the transformation of mouse hepatoma H22 cells in vitro and in vivo. Oligonucleotides (2009) 0.76
Oleanolic acid and ursolic acid inhibit proliferation in transformed rat hepatic oval cells. World J Gastroenterol (2014) 0.76
Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease. World J Gastroenterol (2016) 0.76
Targeting the Notch signaling pathway in cancer therapeutics. Thorac Cancer (2014) 0.75
Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis. J Clin Med (2015) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Cancer stem cells: an old idea--a paradigm shift. Cancer Res (2006) 9.76
Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell (2008) 6.48
Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology (2007) 5.75
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A (2004) 5.32
Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology (2006) 4.61
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res (2008) 4.17
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene (2007) 3.96
Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis (2007) 3.75
A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3. Cancer Res (1962) 3.68
Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene. Cancer Res (1956) 3.58
Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol (2004) 3.41
The canals of Hering and hepatic stem cells in humans. Hepatology (1999) 2.93
Cancer stem cells in radiation resistance. Cancer Res (2007) 2.59
Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology (2005) 2.41
Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. J Hepatol (2003) 2.31
Identifying cancer stem cells in solid tumors: case not proven. Cancer Res (2006) 2.28
Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol (1989) 2.21
Tumour stem cells: the biological concept and its application in cancer treatment. Radiother Oncol (1994) 2.16
Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology (2001) 2.12
Identification of local and circulating cancer stem cells in human liver cancer. Hepatology (2008) 2.02
ETHIONINE CARCINOGENESIS. Adv Cancer Res (1963) 1.97
Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest (1994) 1.93
Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci U S A (2002) 1.90
A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells (2007) 1.87
'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology (1996) 1.83
Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res (1988) 1.78
Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br J Cancer (1978) 1.60
Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology (1992) 1.58
Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol (1998) 1.57
Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology (2008) 1.56
Histochemical studies of mouse liver after single feeding of carbon tetrachloride. AMA Arch Pathol (1950) 1.54
An evaluation of cellular lineages in the pathogenesis of experimental hepatocellular carcinoma. Hepatology (1982) 1.53
Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res (2007) 1.50
Cancer and the immortal strand hypothesis. Genetics (2006) 1.45
Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology (2007) 1.42
Ductular reaction in the liver. Pathol Res Pract (1995) 1.39
Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol (1998) 1.33
Identification of bipotential progenitor cells in human liver regeneration. Lab Invest (1996) 1.26
Analysis of cell cycle compartments of hepatocytes after partial hepatecomy. Cell Tissue Kinet (1976) 1.22
Comparison of liver progenitor cells in human atypical ductular reactions with those seen in experimental models of liver injury. Hepatology (1998) 1.21
Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology (2007) 1.21
Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures. Hepatology (2002) 1.20
Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. A study of 70 cases collected in Japan. Cancer (1970) 1.20
Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction. Am J Pathol (1992) 1.16
Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis. Acta Pathol Microbiol Scand (1969) 1.16
Cellular origin of hepatocellular carcinomas. Semin Cell Dev Biol (2002) 1.16
Tumour stem cells: facts, interpretation and consequences. Radiother Oncol (1994) 1.13
Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Am J Pathol (1983) 1.12
Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer (1989) 1.08
Leukemia: stem cells, maturation arrest, and differentiation therapy. Stem Cell Rev (2005) 1.06
Small epithelial cells in extrahepatic biliary atresia: electron microscopic and immunoelectron microscopic findings suggest a close relationship to liver progenitor cells. Histopathology (1999) 1.04
Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol (2007) 1.02
The present status of the blocked ontogeny hypothesis of neoplasia: the thalassemia connection. Oncodev Biol Med (1981) 1.02
Recent trends in cancer biochemistry: the importance of studies on fetal tissue. Proc Can Cancer Conf (1969) 1.01
The development of proliferating ductular structures in liver disease. An immunohistochemical study. Arch Pathol Lab Med (1990) 1.01
Cancer stem cells and differentiation therapy. Tumour Biol (2006) 0.99
Neoplastic progression in experimental hepatocarcinogenesis. Biochim Biophys Acta (1984) 0.98
Cell population dynamics in the liver. A review of quantitative morphological techniques applied to the study of physiological and pathological growth. Exp Mol Pathol (1966) 0.97
Characterization of ductular hepatocytes in primary liver allograft failure. Mod Pathol (1997) 0.97
DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival. Cell Biol Toxicol (1997) 0.95
The nature and origin of proliferated bile ductules in alcoholic liver disease. Am J Clin Pathol (1983) 0.95
Ultrastructural localisation of alpha-fetoprotin (AFP) in regenerating mouse liver poisoned with CCL4. 1. Reexpression of AFP in differentiated hepatocytes. Histochemistry (1984) 0.93
The relation of mesenchymal cell products to hepatic epithelial systems. Prog Liver Dis (1990) 0.90
Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv Enzyme Regul (1984) 0.90
Intrasplenic hepatocyte transplantation in rats with experimental liver injury: morphological and morphometric studies. J Pathol (1989) 0.90
Acute carbon tetrachloride hepatic injury; composite histological, histochemical and biochemical study. I. Histological and histochemical studies. Acta Pathol Microbiol Scand (1955) 0.89
Potential gene therapy strategies for cancer stem cells. Curr Gene Ther (2006) 0.89
Relationship of rat alpha 1-fetoprotein to growth rate and chromosome composition of Morris hepatomas. Cancer Res (1974) 0.87
Sequential cellular changes during chemical carcinogenesis. J Cancer Res Clin Oncol (1984) 0.86
Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogens. J Cancer Res Clin Oncol (1983) 0.86
Expression of c-kit protooncogene in human hepatocellular carcinoma. Cancer Lett (2005) 0.84
Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study. Vet Pathol (1988) 0.84
Aldolase isozymes in rat tumor cells. Biochem Biophys Res Commun (1968) 0.84
The natural history of neoplastic development: the relation of experimental models to human cancer. Cancer (1982) 0.81
Primary malignant hepatic tumours in childhood. Virchows Arch A Pathol Anat Histopathol (1985) 0.79
Aldolase isozymes in cancer. Eur J Cancer (1966) 0.79
Hepatic neoplasia: reflections and ruminations. Virchows Arch (1995) 0.79
The hepatitis-associated bile duct lesion. Liver (1993) 0.77
Immature hepatic tumor of bimodal differentiation in a young adult patient: a novel lesion expressing beta-catenin and mimicking a distinct phase of hepatogenesis. J Hepatol (2001) 0.77
On the concept of minimum deviation in the study of the biochemistry of cancer. Cancer Res (1968) 0.77
Malignant mouse-liver tumors resembling human hepatoblastomas. J Natl Cancer Inst (1973) 0.76
Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell (2010) 2.43
Unexpected artifacts raise new caution in stem cell culture research. Hepatology (2004) 1.42
Derivation, characterization, and phenotypic variation of hepatic progenitor cell lines isolated from adult rats. Hepatology (2002) 1.03
Targeted deletion of hepatocyte Ikkbeta confers growth advantages. Biochem Biophys Res Commun (2009) 0.86
Hepatic progenitor cell lines from allyl alcohol-treated adult rats are derived from gamma-irradiated mouse STO cells. Stem Cells (2003) 0.79
Embryonic mouse STO cell-derived xenografts express hepatocytic functions in the livers of nonimmunosuppressed adult rats. Stem Cells (2005) 0.78
Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes. Hepat Med (2010) 0.77
Ectopic expression of CD74 in Ikkβ-deleted mouse hepatocytes. Acta Histochem (2010) 0.76